At the same time, dyslipidemia is associated with systemic inflammation, characterized by elevated levels of cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) [66]. The gene discussed is IL6; the disease is metabolic syndrome.